Michael D. Ezekowitz

73.2k citations
270 papers · 48.3k · 19 hit papers · h-index 75

Impact in

    • Venous Thromboembolism Diagnosis and Management
    • Atrial Fibrillation Management and Outcomes
    • Cardiac Arrhythmias and Treatments
    • Antiplatelet Therapy and Cardiovascular Diseases
    • Cardiac electrophysiology and arrhythmias
    • Cardiac pacing and defibrillation studies

Papers in

    • Atrial Fibrillation Management and Outcomes 184
    • Cardiac Arrhythmias and Treatments 43
    • Antiplatelet Therapy and Cardiovascular Diseases 28
    • Cardiac electrophysiology and arrhythmias 19
    • Venous Thromboembolism Diagnosis and Management 30

Michael D. Ezekowitz

267 papers receiving 46.9k citations

Michael D. Ezekowitz's Hit Papers

2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons 2019 · 1.9k citations
1.9k0+5+10Years since publication10002.0k3.0k4.0k5.0k

Peers

Michael D. Ezekowitz
Comparison fields: 5 of 179
  • Internal Medicine 8.2k
  • Cardiology and Cardiovascular Medicine 36.3k
  • Epidemiology 4.5k
  • Neurology 1.4k
  • Hematology 963
Replace Stuart J. Connolly with:
Stuart J. Connolly Canada
Jonathan L. Halperin United States
Elaine M. Hylek United States
Kenneth W. Mahaffey United States
Lars Wallentin Sweden
John W. Eikelboom Canada
Alan S. Go United States
Keith A.A. Fox United Kingdom
Basil S. Lewis Israel
Christopher B. Granger United States
Michael D. Ezekowitz relative to Stuart J. Connolly Canada Stuart J. Connolly's profile →
Citations per field
00.5×1.6×
Stuart J. Connolly · 1×
Citations per year

Countries citing papers authored by Michael D. Ezekowitz

Since Specialization
Citations

This map shows the geographic impact of Michael D. Ezekowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael D. Ezekowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael D. Ezekowitz more than expected).

Fields of papers citing papers by Michael D. Ezekowitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael D. Ezekowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael D. Ezekowitz. The network helps show where Michael D. Ezekowitz may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael D. Ezekowitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael D. Ezekowitz Line = papers co-authored together Michael D. Ezekowitz links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 270 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
Hit paper breakdown →
20098060
2
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
Hit paper breakdown →
20145472
3
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
Hit paper breakdown →
20143381
4
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
Hit paper breakdown →
20133367
5
Forecasting the Future of Cardiovascular Disease in the United States
Hit paper breakdown →
20112418
6
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
Hit paper breakdown →
20142268
7
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons
Hit paper breakdown →
20191871
8
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
Hit paper breakdown →
20141571
9
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
Hit paper breakdown →
20191534
10
2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Updating the 2006 Guideline)
Hit paper breakdown →
20101026
11
Warfarin in the Prevention of Stroke Associated with Nonrheumatic Atrial Fibrillation
Hit paper breakdown →
1992849
12
Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial
Hit paper breakdown →
2010733
13
The Effect of Dabigatran Plasma Concentrations and Patient Characteristics on the Frequency of Ischemic Stroke and Major Bleeding in Atrial Fibrillation Patients
Hit paper breakdown →
2013636
14 2005485
15
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
Hit paper breakdown →
2014439
16
Periprocedural Bleeding and Thromboembolic Events With Dabigatran Compared With Warfarin
Hit paper breakdown →
2012401
17 2011355
18
Concomitant Use of Antiplatelet Therapy with Dabigatran or Warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Trial
Hit paper breakdown →
2012343
19
The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study
Hit paper breakdown →
2016336
20 2007334

About Michael D. Ezekowitz

Michael D. Ezekowitz is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine, Radiology, Nuclear Medicine and Imaging, Surgery and Pulmonary and Respiratory Medicine, having authored 270 papers that have together received 48.3k indexed citations. Recurring topics across this work include Atrial Fibrillation Management and Outcomes (184 papers), Cardiac Arrhythmias and Treatments (43 papers), Venous Thromboembolism Diagnosis and Management (30 papers), Antiplatelet Therapy and Cardiovascular Diseases (28 papers), Cardiac Imaging and Diagnostics (25 papers), Cardiac electrophysiology and arrhythmias (19 papers), Health Systems, Economic Evaluations, Quality of Life (11 papers) and Coronary Interventions and Diagnostics (10 papers). The work is most often cited by research in Internal Medicine (8.2k citations), Cardiology and Cardiovascular Medicine (36.3k citations), Epidemiology (4.5k citations), Neurology (1.4k citations) and Hematology (963 citations). Michael D. Ezekowitz has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Stuart J. Connolly, Salim Yusuf, Lars Wallentin, Paul Reilly, Craig T. January, Cynthia M. Tracy, L. Samüel Wann, Patrick T. Ellinor, Joseph C. Cleveland and Hugh Calkins. Their work appears in journals such as Circulation, Journal of the American College of Cardiology, American Heart Journal, The American Journal of Cardiology and European Heart Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact